Acceptance of biosimilars grows but greater use may hinge on switching, interchangeability studiesSeptember 30, 2021Rheumatoid ArthritisPsoriatic ArthritisSpondyloarthropathiesPediatricsAnkylosing spondylitisLupus & Connective Tissue Diseases
European agency recommends two new adalimumab biosimilarsSeptember 20, 2021Rheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisPediatricsAnkylosing spondylitis
Medicare patients’ cost burden for specialty psoriasis, PsA drugs remains highSeptember 15, 2021Psoriatic Arthritis
Cannabidiol found no better than placebo for hand arthritis painSeptember 15, 2021Psoriatic ArthritisOsteoarthritis
Three JAK inhibitors get boxed warnings, modified indicationsSeptember 2, 2021Rheumatoid ArthritisPsoriatic ArthritisPediatrics
Western diet promoted skin, joint inflammation in preclinical studyAugust 16, 2021Psoriatic Arthritis
HBV screening often incomplete or forgone when starting tocilizumab, tofacitinibAugust 9, 2021Rheumatoid ArthritisPediatricsPsoriatic ArthritisLupus & Connective Tissue Diseases
COVID-19 vaccine hesitancy still weighs heavy for some rheumatic disease patientsJuly 21, 2021COVID-19 UpdatesRheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisAnkylosing spondylitisLupus & Connective Tissue Diseases
‘Gold cards’ allow Texas docs to skip prior authorizationsJuly 16, 2021Business of MedicinePsoriatic ArthritisMixed Topics
Patients on methotrexate show T-cell response to Pfizer vaccineJuly 13, 2021COVID-19 UpdatesPsoriatic Arthritis
